Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01146912 · ClinicalTrials.gov registry record · NA
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 30,537
- Enrollment target
NCT01146912 is a NA study that has completed, run by Columbia University. The registered enrollment target is 30,537 participants.
The verdict
NCT01146912, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30,537 participants
- Enrollment target
Study Summary
The Advisory Committee on Immunization Practices (ACIP)recommends that the flu vaccine be administered annually to all children aged 6 months to 18 years as well as women who are pregnant during the influenza season. Nevertheless, targeting and mobilizing these populations has been difficult and influenza immunization rates nationwide remain low. Immunization reminder-recalls have been shown to be effective, but have had limited ability to rapidly identify and reach large target populations in a cost-effective manner. Evidence on how to optimally design these systems is not yet available and thus text message immunization alerts have not been widely implemented. The investigators propose to implement and evaluate tailored, targeted influenza text message reminders in urban pediatric and pregnant populations.
Interventions
- OTHER Text Message
- OTHER automated call
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,537 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01146912
The ClinicalTrials.gov registry entry for NCT01146912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30,537 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Text Message is the first listed.
NCT01146912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01146912 about?
NCT01146912 is a clinical study titled "TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations". The Advisory Committee on Immunization Practices (ACIP)recommends that the flu vaccine be administered annually to all children aged 6 months to 18 years as well as women who are pregnant during the influenza season. Nevertheless, targeting and mobilizing these populations has been difficult and inf...
What is the current status of trial NCT01146912?
This trial is currently completed. It is a NA study. The enrollment target is 30,537 participants. The study started on 2010-06. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01146912?
The interventions under investigation include: Text Message (OTHER), automated call (OTHER).
Who is sponsoring clinical trial NCT01146912?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.